Pyxis Oncology Inc (PYXS) — Tangible Net Worth Ratio
Pyxis Oncology Inc (PYXS) has a Tangible Net Worth Ratio of 96.5% as of September 2025. This metric is calculated by deducting intangible assets ($2.43 Million) from net assets ($68.78 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Pyxis Oncology Inc annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Pyxis Oncology Inc Tangible Net Worth Ratio (2021–2024)
This chart shows how Pyxis Oncology Inc's Tangible Net Worth Ratio has changed across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 96.5%, reflecting net assets of $68.78 Million with intangible assets of $2.43 Million USD. For live market cap and overall valuation, see PYXS market cap overview.
Annual Tangible Net Worth Ratio for Pyxis Oncology Inc (2021–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Pyxis Oncology Inc from 2021 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore how much does Pyxis Oncology Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.8% | $120.75 Million | $2.60 Million | $157.18 Million | ▲ +17.2 pp |
| 2023 | 80.7% | $125.70 Million | $24.31 Million | $173.73 Million | ▼ -19.3 pp |
| 2022 | 100.0% | $160.82 Million | $0.00 | $211.38 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $261.31 Million | $0.00 | $280.02 Million | — |